Sweetgreen, Inc. (SG) earnings date, results and what the price requires
NYSE · SEC CIK 0001477815 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 28, 2026 | Aug 6, 2026 | $192.7M | $-26.3M | $-0.22 | Filing |
| Mar 29, 2026 | May 7, 2026 | $161.5M | $125.8M | $1.05 | Filing |
| Dec 28, 2025 | Feb 26, 2026 | $155.2M | $-49.7M | $-0.42 | Filing |
| Sep 28, 2025 | Nov 6, 2025 | $172.4M | $-36.1M | $-0.31 | Filing |
| Jun 29, 2025 | Aug 7, 2025 | $185.6M | $-23.2M | $-0.20 | Filing |
| Mar 30, 2025 | May 8, 2025 | $166.3M | $-25.0M | $-0.21 | Filing |
| Dec 29, 2024 | Feb 26, 2025 | $160.9M | $-29.0M | $-0.25 | Filing |
| Sep 29, 2024 | Nov 7, 2024 | $173.4M | $-20.8M | $-0.18 | Filing |
What would Sweetgreen, Inc. have to report for its valuation to change?
At $10.60, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 55.4% a year, to $0.91. On that path the next quarter needs diluted EPS near $-0.48, against $-0.31 in the quarter ended Sep 28, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 55.4% | 55.4% |
| EPS needed in final year | $0.91 | $0.91 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. SG goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.